Find us on:


Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.
Publication Type
Journal Article
Research Type
Reported as
Clinical Trial
October 01, 2016
David Mischoulon, Lindsay Hylek, Albert S. Yeung, Alisabet J. Clain, Lee Baer, Cristina Cusin, Dawn Flosnik Ionescu, Jonathan E. Alpert, David P. Soskin, Maurizio Fava
The Massachusetts General Hospital; Harvard Medical School

BACKGROUND: Given the proposed dopaminergic mechanism of low-dose naltrexone (LDN), we examined its efficacy as augmentation for depressive breakthrough on pro-dopaminergic antidepressant regimens.

METHODS: 12 adults (67% female, mean age = 45±12) with recurrent DSM-IV major depressive disorder (MDD) on dopaminergic antidepressant regimens (stimulants, dopamine agonists, bupropion [≥300mg/day], aripiprazole [≤2.5mg/day], or sertraline [≥150mg/day]) were randomized to naltrexone 1mg b.i.d. (n=6) or placebo (n=6) augmentation for 3 weeks.

RESULTS: All subjects completed the trial. Hamilton Depression Rating Scale (HAM-D-17) scores (primary outcome measure) decreased from 21.2±2.0 to 11.7±7.7 for LDN, from 23.7±2.3 to 17.8±5.9 for placebo (Cohen's d=0.62; p=0.3 between treatment groups). HAM-D-28 scores decreased from 26.2±4.0 to 12.0±9.8 for LDN, from 26.3±2.6 to 19.8±6.6 for placebo (d=1.15; p=0.097). Montgomery-Asberg Depression Rating Scale (MADRS-10 item) scores decreased from 30.4±4.9 to 12.2±8.4 for LDN, from 30.7±4.3 to 22.8±8.5) for placebo (d=1.45; p=0.035). MADRS-15 item scores decreased from 36.6±6.2 to 13.2±8.8 for LDN, from 36.7±4.2 to 26.0±10.0 for placebo (d=1.49; p=0.035). Clinical Global Improvement Scale-Severity (CGI-S) scores decreased from 4.3±0.5 to 3.0±1.1 for LDN, from 4.3±0.5 to 4.0±0.6 for placebo (d=1.22; p=0.064).

LIMITATIONS: Small study; restrictions on allowed antidepressants.

CONCLUSION: LDN augmentation showed some benefit for MDD relapse on dopaminergic agents. Confirmation in larger studies is needed.

petco cbd oil painless cbd oil cbd salve sisters of the valley natural thc free cbd vape oil cheap cbd isolate cbd nanotechnology versus regular cbd oil cbd oil and drug screens 101 cbd cloud9 cbd flora cbd oil colorado cbd isolate snowboard melbourne cbd side effects review list various sources of pain molecule simple definition 802 hemp oil medical term for seizures best cbd gummies 2019 intestino en ingles white label cbd cbd oil md hemp oil cbd arthritis cbd oil treatment for ms ms o skin care is hempworkx cbd oil pharmaceutical cbd oil from hemp legality

vape no A Tag

dr axe weight loss jello for weight loss topiramate 50 mg weight loss reviews saffron extract for weight loss meal replacement drinks weight loss chitosan weight loss ear magnets for weight loss reviews weight loss pills that really works good weight loss products shred360 diet pills weight loss pills like phentermine cycling and weight loss pills for weight loss that work turmeric powder for weight loss the best working weight loss pills best caffeine free diet pills ab weight loss pills quick weight loss center gluten free men diet pills top rated weight loss pills for women slim v diet pills demograss weight loss pills 7 day smoothie diet weight loss weight loss products reviewed pur cambogia chicken breast recipes for weight loss

medicine for ed for hims reviews penis pills results meth erectile dysfunction l arginine boners what helps with erectile dysfunction big penis blog big jewish dick how to get a huge erection cocaine sex drive man peins weed erectile dysfunction how to increase low testosterone breast enhancement pills walmart healthy male penis penis pumps that work what causes erectile disfunction tadalista vs cialis cocaine and erection most powerful drugs what are dick rings for what is sildenafil for rohypnols effects on men really long penis how long for testosterone shot to work average black penile length